Wendy’s has rejected a $1.4 billion buyout offer from an investor group led by Nelson Peltz, deeming the bid too low. The company simultaneously adopted a “poison pill” plan designed to thwart a hostile takeover. Shares of the burger chain initially spiked 14% following the offer last Wednesday, and rose more than 2% Thursday alongside the announcement of better-than-expected third-quarter performance.
Wendy’s independent directors unanimously rejected the offer from Trian Fund Management and its partners, stating it “substantially undervalues” the company. The shareholder rights plan, or “poison pill,” will be triggered if any person or group acquires 15% or more of Wendy’s shares, granting other shareholders the right to purchase discounted shares. Trian Fund Management and its partners currently hold 16.3% of the company’s shares, and the plan will remain in effect for one year.
The decision comes as Wendy’s, like other fast-food chains, has navigated inflationary pressures. The company has raised prices to offset rising costs for labor, food, and packaging, leading to a decrease in visits from lower-income customers.
Our reading is that Wendy’s leadership believes the offered price does not reflect the company’s current or potential value, even with acknowledged challenges like decreased visits from price-sensitive customers. The adoption of the “poison pill” demonstrates a firm intention to remain independent and resist acquisition, even from a significant existing shareholder. The simultaneous announcement of positive third-quarter performance appears strategically timed to bolster this position and justify the rejection.
Read the original coverage
💬 Comments
📜 Comment Policy